查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1873515

Thebain：全球市场占有率和排名、总收入和需求预测（2025-2031年）

Thebaine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 95 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年全球蒂巴因市场规模估计为 5,960 万美元，预计到 2031 年将调整至 5,840 万美元，在 2025-2031 年预测期内的复合年增长率为 -0.3%。

本报告对近期关税调整和国际战略反制措施对德班跨境产业布局、资本配置模式、区域经济相互依存关係和供应链重组的影响进行了全面评估。

蒂巴因（又称对吗啡）是一种白色结晶质的有毒生物碱，在合成纯品中微溶于水。虽然蒂巴因本身没有治疗用途，但它是从伊朗罂粟（Papaver bracteatum）中提取的主要生物碱，也是多种化合物的工业来源，包括羟考酮、oxymorphone、纳布啡、纳洛酮、纳曲酮、Buprenornhine和依托啡。

蒂巴因市场在全球医药和鸦片类药物供应链中扮演着至关重要的角色。蒂巴因是一种存在于罂粟中的天然生物碱，主要用作合成多种半合成鸦片类药物的前体，包括羟考酮、Buprenornhine和纳洛酮。与氢可酮和可待因不同，蒂巴因本身并不用于治疗，因为其在治疗剂量下具有兴奋作用和潜在毒性。它的价值在于其适用于药物生产中的化学结构修饰。对蒂巴因的需求与製药业的需求密切相关，尤其是在疼痛管理、成瘾治疗和麻醉领域。

市场受到法规结构、地缘政治趋势和不断变化的公共卫生优先事项等复杂因素的影响。蒂巴因属于管制药物，因此受到严格的管制，影响其生产和贸易。此外，受多个国家阿片类药物危机的影响，人们对阿片类药物使用的态度正在转变，这促使处方行为发生改变，并推动对替代疗法的研究。这些因素，以及合成生物学和罂粟种植技术的创新，持续影响蒂巴因市场的发展轨迹，使其成为全球製药业中一个具有重要战略意义但又受到严格监管的领域。

本报告旨在对全球蒂巴因市场进行全面分析，重点关注总销售量、收入、价格、市场份额和主要企业的排名，并按地区/国家、类型和应用对蒂巴因进行分析。

蒂巴因市场规模、估算和预测以销售量（吨）和收入（百万美元）为单位呈现，以2024年为基准年，并包含2020年至2031年的历史数据和预测数据。报告采用定量和定性分析相结合的方法，帮助读者制定蒂巴因业务和成长策略，评估市场竞争，分析自身在当前市场中的地位，并做出明智的商业决策。

市场区隔

公司

  • Sun Pharmaceutical
  • Tasmanian Alkaloids
  • Alcaliber
  • TPI
  • Cepia-Sanofi
  • Taj Pharmaceuticals
  • Gansu Alkaloids

按类型分類的细分市场

  • 罂粟茎萃取物
  • 从鸦片中撷取

应用领域

  • 羟考酮
  • 氢可酮
  • Buprenornhine
  • 其他的

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Thebaine was estimated to be worth US$ 59.6 million in 2024 and is forecast to a readjusted size of US$ 58.4 million by 2031 with a CAGR of -0.3% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Thebaine cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Thebaine, also known as paramorphine, is a white, crystalline, slightly water-soluble (in pure form after a synthesis), poisonous alkaloid. Thebaine is not used therapeutically, but as the main alkaloid extracted from papaver bracteatum (Iranian poppy), it can be converted industrially into a variety of compounds including oxycodone, oxymorphone, nalbuphine, naloxone, naltrexone, buprenorphine and etorphine.

The thebaine market plays a vital role within the global pharmaceutical and opioid supply chain. Thebaine, a naturally occurring alkaloid found in opium poppy, is primarily used as a precursor in the synthesis of various semi-synthetic opioids such as oxycodone, buprenorphine, and naloxone. Unlike morphine or codeine, thebaine itself is not used therapeutically due to its stimulatory and potentially toxic effects at therapeutic doses. Instead, its value lies in its chemical structure, which lends itself well to modification in pharmaceutical manufacturing. Demand for thebaine is closely tied to the needs of the pharmaceutical industry, particularly in pain management, addiction treatment, and anesthesia.

The market is influenced by a complex interplay of regulatory frameworks, geopolitical dynamics, and evolving public health priorities. Stringent controls are in place due to thebaine's association with controlled substances, which affects both production and trade. Additionally, shifting attitudes toward opioid use-spurred by the opioid crisis in several countries-are prompting changes in prescribing practices and encouraging research into alternative therapies. These factors, along with innovation in synthetic biology and poppy cultivation, continue to shape the trajectory of the thebaine market, making it a strategically significant but highly regulated segment of the global pharmaceutical industry.

This report aims to provide a comprehensive presentation of the global market for Thebaine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Thebaine by region & country, by Type, and by Application.

The Thebaine market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thebaine.

Market Segmentation

By Company

  • Sun Pharmaceutical
  • Tasmanian Alkaloids
  • Alcaliber
  • TPI
  • Cepia-Sanofi
  • Taj Pharmaceuticals
  • Gansu Alkaloids

Segment by Type

  • Extraction from Poppy Straw
  • Extraction from Opium

Segment by Application

  • Oxycodone
  • Hydrocodone
  • Buprenorphine
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Thebaine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Thebaine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Thebaine in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Thebaine Product Introduction
  • 1.2 Global Thebaine Market Size Forecast
    • 1.2.1 Global Thebaine Sales Value (2020-2031)
    • 1.2.2 Global Thebaine Sales Volume (2020-2031)
    • 1.2.3 Global Thebaine Sales Price (2020-2031)
  • 1.3 Thebaine Market Trends & Drivers
    • 1.3.1 Thebaine Industry Trends
    • 1.3.2 Thebaine Market Drivers & Opportunity
    • 1.3.3 Thebaine Market Challenges
    • 1.3.4 Thebaine Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Thebaine Players Revenue Ranking (2024)
  • 2.2 Global Thebaine Revenue by Company (2020-2025)
  • 2.3 Global Thebaine Players Sales Volume Ranking (2024)
  • 2.4 Global Thebaine Sales Volume by Company Players (2020-2025)
  • 2.5 Global Thebaine Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Thebaine Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Thebaine Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Thebaine
  • 2.9 Thebaine Market Competitive Analysis
    • 2.9.1 Thebaine Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Thebaine Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thebaine as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Extraction from Poppy Straw
    • 3.1.2 Extraction from Opium
  • 3.2 Global Thebaine Sales Value by Type
    • 3.2.1 Global Thebaine Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Thebaine Sales Value, by Type (2020-2031)
    • 3.2.3 Global Thebaine Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Thebaine Sales Volume by Type
    • 3.3.1 Global Thebaine Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Thebaine Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Thebaine Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Thebaine Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Oxycodone
    • 4.1.2 Hydrocodone
    • 4.1.3 Buprenorphine
    • 4.1.4 Others
  • 4.2 Global Thebaine Sales Value by Application
    • 4.2.1 Global Thebaine Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Thebaine Sales Value, by Application (2020-2031)
    • 4.2.3 Global Thebaine Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Thebaine Sales Volume by Application
    • 4.3.1 Global Thebaine Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Thebaine Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Thebaine Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Thebaine Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Thebaine Sales Value by Region
    • 5.1.1 Global Thebaine Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Thebaine Sales Value by Region (2020-2025)
    • 5.1.3 Global Thebaine Sales Value by Region (2026-2031)
    • 5.1.4 Global Thebaine Sales Value by Region (%), (2020-2031)
  • 5.2 Global Thebaine Sales Volume by Region
    • 5.2.1 Global Thebaine Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Thebaine Sales Volume by Region (2020-2025)
    • 5.2.3 Global Thebaine Sales Volume by Region (2026-2031)
    • 5.2.4 Global Thebaine Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Thebaine Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Thebaine Sales Value, 2020-2031
    • 5.4.2 North America Thebaine Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Thebaine Sales Value, 2020-2031
    • 5.5.2 Europe Thebaine Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Thebaine Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Thebaine Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Thebaine Sales Value, 2020-2031
    • 5.7.2 South America Thebaine Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Thebaine Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Thebaine Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Thebaine Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Thebaine Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Thebaine Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Thebaine Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Thebaine Sales Value, 2020-2031
    • 6.3.2 United States Thebaine Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Thebaine Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Thebaine Sales Value, 2020-2031
    • 6.4.2 Europe Thebaine Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Thebaine Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Thebaine Sales Value, 2020-2031
    • 6.5.2 China Thebaine Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Thebaine Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Thebaine Sales Value, 2020-2031
    • 6.6.2 Japan Thebaine Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Thebaine Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Thebaine Sales Value, 2020-2031
    • 6.7.2 South Korea Thebaine Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Thebaine Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Thebaine Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Thebaine Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Thebaine Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Thebaine Sales Value, 2020-2031
    • 6.9.2 India Thebaine Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Thebaine Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Sun Pharmaceutical
    • 7.1.1 Sun Pharmaceutical Company Information
    • 7.1.2 Sun Pharmaceutical Introduction and Business Overview
    • 7.1.3 Sun Pharmaceutical Thebaine Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Sun Pharmaceutical Thebaine Product Offerings
    • 7.1.5 Sun Pharmaceutical Recent Development
  • 7.2 Tasmanian Alkaloids
    • 7.2.1 Tasmanian Alkaloids Company Information
    • 7.2.2 Tasmanian Alkaloids Introduction and Business Overview
    • 7.2.3 Tasmanian Alkaloids Thebaine Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Tasmanian Alkaloids Thebaine Product Offerings
    • 7.2.5 Tasmanian Alkaloids Recent Development
  • 7.3 Alcaliber
    • 7.3.1 Alcaliber Company Information
    • 7.3.2 Alcaliber Introduction and Business Overview
    • 7.3.3 Alcaliber Thebaine Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Alcaliber Thebaine Product Offerings
    • 7.3.5 Alcaliber Recent Development
  • 7.4 TPI
    • 7.4.1 TPI Company Information
    • 7.4.2 TPI Introduction and Business Overview
    • 7.4.3 TPI Thebaine Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 TPI Thebaine Product Offerings
    • 7.4.5 TPI Recent Development
  • 7.5 Cepia-Sanofi
    • 7.5.1 Cepia-Sanofi Company Information
    • 7.5.2 Cepia-Sanofi Introduction and Business Overview
    • 7.5.3 Cepia-Sanofi Thebaine Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Cepia-Sanofi Thebaine Product Offerings
    • 7.5.5 Cepia-Sanofi Recent Development
  • 7.6 Taj Pharmaceuticals
    • 7.6.1 Taj Pharmaceuticals Company Information
    • 7.6.2 Taj Pharmaceuticals Introduction and Business Overview
    • 7.6.3 Taj Pharmaceuticals Thebaine Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Taj Pharmaceuticals Thebaine Product Offerings
    • 7.6.5 Taj Pharmaceuticals Recent Development
  • 7.7 Gansu Alkaloids
    • 7.7.1 Gansu Alkaloids Company Information
    • 7.7.2 Gansu Alkaloids Introduction and Business Overview
    • 7.7.3 Gansu Alkaloids Thebaine Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Gansu Alkaloids Thebaine Product Offerings
    • 7.7.5 Gansu Alkaloids Recent Development

8 Industry Chain Analysis

  • 8.1 Thebaine Industrial Chain
  • 8.2 Thebaine Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Thebaine Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Thebaine Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Thebaine Market Trends
  • Table 2. Thebaine Market Drivers & Opportunity
  • Table 3. Thebaine Market Challenges
  • Table 4. Thebaine Market Restraints
  • Table 5. Global Thebaine Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Thebaine Revenue Market Share by Company (2020-2025)
  • Table 7. Global Thebaine Sales Volume by Company (2020-2025) & (MT)
  • Table 8. Global Thebaine Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Thebaine Price by Company (2020-2025) & (USD/Kg)
  • Table 10. Key Manufacturers Thebaine Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Thebaine Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Thebaine
  • Table 13. Global Thebaine Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thebaine as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Thebaine Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Thebaine Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Thebaine Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Thebaine Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Thebaine Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Thebaine Sales Volume by Type: 2020 VS 2024 VS 2031 (MT)
  • Table 22. Global Thebaine Sales Volume by Type (2020-2025) & (MT)
  • Table 23. Global Thebaine Sales Volume by Type (2026-2031) & (MT)
  • Table 24. Global Thebaine Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Thebaine Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Thebaine Price by Type (2020-2025) & (USD/Kg)
  • Table 27. Global Thebaine Price by Type (2026-2031) & (USD/Kg)
  • Table 28. Global Thebaine Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Thebaine Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Thebaine Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Thebaine Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Thebaine Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Thebaine Sales Volume by Application: 2020 VS 2024 VS 2031 (MT)
  • Table 34. Global Thebaine Sales Volume by Application (2020-2025) & (MT)
  • Table 35. Global Thebaine Sales Volume by Application (2026-2031) & (MT)
  • Table 36. Global Thebaine Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Thebaine Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Thebaine Price by Application (2020-2025) & (USD/Kg)
  • Table 39. Global Thebaine Price by Application (2026-2031) & (USD/Kg)
  • Table 40. Global Thebaine Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Thebaine Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Thebaine Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Thebaine Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Thebaine Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Thebaine Sales Volume by Region (MT): 2020 VS 2024 VS 2031
  • Table 46. Global Thebaine Sales Volume by Region (2020-2025) & (MT)
  • Table 47. Global Thebaine Sales Volume by Region (2026-2031) & (MT)
  • Table 48. Global Thebaine Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Thebaine Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Thebaine Average Price by Region (2020-2025) & (USD/Kg)
  • Table 51. Global Thebaine Average Price by Region (2026-2031) & (USD/Kg)
  • Table 52. Key Countries/Regions Thebaine Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Thebaine Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Thebaine Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Thebaine Sales Volume, (2020-2025) & (MT)
  • Table 56. Key Countries/Regions Thebaine Sales Volume, (2026-2031) & (MT)
  • Table 57. Sun Pharmaceutical Company Information
  • Table 58. Sun Pharmaceutical Introduction and Business Overview
  • Table 59. Sun Pharmaceutical Thebaine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 60. Sun Pharmaceutical Thebaine Product Offerings
  • Table 61. Sun Pharmaceutical Recent Development
  • Table 62. Tasmanian Alkaloids Company Information
  • Table 63. Tasmanian Alkaloids Introduction and Business Overview
  • Table 64. Tasmanian Alkaloids Thebaine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 65. Tasmanian Alkaloids Thebaine Product Offerings
  • Table 66. Tasmanian Alkaloids Recent Development
  • Table 67. Alcaliber Company Information
  • Table 68. Alcaliber Introduction and Business Overview
  • Table 69. Alcaliber Thebaine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 70. Alcaliber Thebaine Product Offerings
  • Table 71. Alcaliber Recent Development
  • Table 72. TPI Company Information
  • Table 73. TPI Introduction and Business Overview
  • Table 74. TPI Thebaine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 75. TPI Thebaine Product Offerings
  • Table 76. TPI Recent Development
  • Table 77. Cepia-Sanofi Company Information
  • Table 78. Cepia-Sanofi Introduction and Business Overview
  • Table 79. Cepia-Sanofi Thebaine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 80. Cepia-Sanofi Thebaine Product Offerings
  • Table 81. Cepia-Sanofi Recent Development
  • Table 82. Taj Pharmaceuticals Company Information
  • Table 83. Taj Pharmaceuticals Introduction and Business Overview
  • Table 84. Taj Pharmaceuticals Thebaine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 85. Taj Pharmaceuticals Thebaine Product Offerings
  • Table 86. Taj Pharmaceuticals Recent Development
  • Table 87. Gansu Alkaloids Company Information
  • Table 88. Gansu Alkaloids Introduction and Business Overview
  • Table 89. Gansu Alkaloids Thebaine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 90. Gansu Alkaloids Thebaine Product Offerings
  • Table 91. Gansu Alkaloids Recent Development
  • Table 92. Key Raw Materials Lists
  • Table 93. Raw Materials Key Suppliers Lists
  • Table 94. Thebaine Downstream Customers
  • Table 95. Thebaine Distributors List
  • Table 96. Research Programs/Design for This Report
  • Table 97. Key Data Information from Secondary Sources
  • Table 98. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Thebaine Product Picture
  • Figure 2. Global Thebaine Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Thebaine Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Thebaine Sales Volume (2020-2031) & (MT)
  • Figure 5. Global Thebaine Sales Price (2020-2031) & (USD/Kg)
  • Figure 6. Thebaine Report Years Considered
  • Figure 7. Global Thebaine Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Thebaine Players Sales Volume Ranking (2024) & (MT)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Thebaine Revenue in 2024
  • Figure 10. Thebaine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Extraction from Poppy Straw Picture
  • Figure 12. Extraction from Opium Picture
  • Figure 13. Global Thebaine Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Thebaine Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Global Thebaine Sales Volume by Type (2020 VS 2024 VS 2031) & (MT)
  • Figure 16. Global Thebaine Sales Volume Market Share by Type, 2024 & 2031
  • Figure 17. Global Thebaine Price by Type (2020-2031) & (USD/Kg)
  • Figure 18. Product Picture of Oxycodone
  • Figure 19. Product Picture of Hydrocodone
  • Figure 20. Product Picture of Buprenorphine
  • Figure 21. Product Picture of Others
  • Figure 22. Global Thebaine Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 23. Global Thebaine Sales Value Market Share by Application, 2024 & 2031
  • Figure 24. Global Thebaine Sales Volume by Application (2020 VS 2024 VS 2031) & (MT)
  • Figure 25. Global Thebaine Sales Volume Market Share by Application, 2024 & 2031
  • Figure 26. Global Thebaine Price by Application (2020-2031) & (USD/Kg)
  • Figure 27. North America Thebaine Sales Value (2020-2031) & (US$ Million)
  • Figure 28. North America Thebaine Sales Value by Country (%), 2024 VS 2031
  • Figure 29. Europe Thebaine Sales Value, (2020-2031) & (US$ Million)
  • Figure 30. Europe Thebaine Sales Value by Country (%), 2024 VS 2031
  • Figure 31. Asia Pacific Thebaine Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. Asia Pacific Thebaine Sales Value by Region (%), 2024 VS 2031
  • Figure 33. South America Thebaine Sales Value, (2020-2031) & (US$ Million)
  • Figure 34. South America Thebaine Sales Value by Country (%), 2024 VS 2031
  • Figure 35. Middle East & Africa Thebaine Sales Value, (2020-2031) & (US$ Million)
  • Figure 36. Middle East & Africa Thebaine Sales Value by Country (%), 2024 VS 2031
  • Figure 37. Key Countries/Regions Thebaine Sales Value (%), (2020-2031)
  • Figure 38. Key Countries/Regions Thebaine Sales Volume (%), (2020-2031)
  • Figure 39. United States Thebaine Sales Value, (2020-2031) & (US$ Million)
  • Figure 40. United States Thebaine Sales Value by Type (%), 2024 VS 2031
  • Figure 41. United States Thebaine Sales Value by Application (%), 2024 VS 2031
  • Figure 42. Europe Thebaine Sales Value, (2020-2031) & (US$ Million)
  • Figure 43. Europe Thebaine Sales Value by Type (%), 2024 VS 2031
  • Figure 44. Europe Thebaine Sales Value by Application (%), 2024 VS 2031
  • Figure 45. China Thebaine Sales Value, (2020-2031) & (US$ Million)
  • Figure 46. China Thebaine Sales Value by Type (%), 2024 VS 2031
  • Figure 47. China Thebaine Sales Value by Application (%), 2024 VS 2031
  • Figure 48. Japan Thebaine Sales Value, (2020-2031) & (US$ Million)
  • Figure 49. Japan Thebaine Sales Value by Type (%), 2024 VS 2031
  • Figure 50. Japan Thebaine Sales Value by Application (%), 2024 VS 2031
  • Figure 51. South Korea Thebaine Sales Value, (2020-2031) & (US$ Million)
  • Figure 52. South Korea Thebaine Sales Value by Type (%), 2024 VS 2031
  • Figure 53. South Korea Thebaine Sales Value by Application (%), 2024 VS 2031
  • Figure 54. Southeast Asia Thebaine Sales Value, (2020-2031) & (US$ Million)
  • Figure 55. Southeast Asia Thebaine Sales Value by Type (%), 2024 VS 2031
  • Figure 56. Southeast Asia Thebaine Sales Value by Application (%), 2024 VS 2031
  • Figure 57. India Thebaine Sales Value, (2020-2031) & (US$ Million)
  • Figure 58. India Thebaine Sales Value by Type (%), 2024 VS 2031
  • Figure 59. India Thebaine Sales Value by Application (%), 2024 VS 2031
  • Figure 60. Thebaine Industrial Chain
  • Figure 61. Thebaine Manufacturing Cost Structure
  • Figure 62. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 63. Bottom-up and Top-down Approaches for This Report
  • Figure 64. Data Triangulation
  • Figure 65. Key Executives Interviewed